Emerald Investment Advisers LLC Invests $5.14 Million in Astera Labs, Inc. $ALAB

Emerald Investment Advisers LLC acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel reports. The fund acquired 10,638 shares of the company’s stock, valued at approximately $5,138,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Reflection Asset Management acquired a new position in Astera Labs in the 4th quarter worth about $25,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs during the fourth quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC raised its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at $1,237,965.10. This represents a 69.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several recent research reports. UBS Group reissued a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Jefferies Financial Group upped their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Finally, Morgan Stanley lifted their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Trading Down 1.9%

NASDAQ ALAB opened at $284.97 on Friday. The stock’s 50 day moving average is $352.70 and its two-hundred day moving average is $244.92. The company has a market capitalization of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the company posted $0.44 EPS. The company’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.